| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/01/2014 | EP2678015A1 Use of nifuratel to treat infections caused by clostridium species |
| 01/01/2014 | EP2678014A2 Prostate cancer therapy with hsp90 inhibitory compounds |
| 01/01/2014 | CN103491980A Photodynamic therapy or diagnostic agent, using infrared-spectrum light |
| 01/01/2014 | CN103491973A Infant formula for use in the prevention of cardiovascular diseases |
| 01/01/2014 | CN103491966A Selection of HCV treatment |
| 01/01/2014 | CN103491952A Novel combination therapy for the treatment of cancer |
| 01/01/2014 | CN103480001A Acupoint massaging assisting preparation, preparation technology and application of preparation technology |
| 01/01/2014 | CN103480000A Therapeutic compositions and the use thereof |
| 01/01/2014 | CN103479590A Preparation method for ZCHH tablets and method for reversing drug tolerance of MRSA (Methicillin-Resistant Staphylococcus Aureus) by using ZCHH and antibiotic together |
| 01/01/2014 | CN103479582A Fast wet-massing method for the preparation of calcium-containing compositions |
| 01/01/2014 | CN102921008B Stable drug composition containing calcium blockers |
| 01/01/2014 | CN102600073B Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method of oily preparation |
| 01/01/2014 | CN101679244B 5-membered heterocyclic derivative and use thereof for medical purposes |
| 12/31/2013 | US8618276 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 12/31/2013 | US8618174 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 12/31/2013 | US8618148 Use of telmisartan for the prevention and treatment of vascular headache |
| 12/31/2013 | US8618136 Methods for the treatment of myeloproliferative diseases using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione |
| 12/31/2013 | US8618130 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 12/31/2013 | US8618093 Hypotensive lipid and timolol compositions and methods of using same |
| 12/31/2013 | US8618086 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 12/31/2013 | US8617872 Compositions for culturing spirochetes |
| 12/31/2013 | US8617822 Method of inhibiting binding or activity of MIF by administering a MIF antagonist |
| 12/31/2013 | US8617621 Composition for enhancing immunity containing plant stem cell line derived from cambium of Panax ginseng including wild ginseng or ginseng as an active ingredient |
| 12/31/2013 | US8617530 Polymer conjugates of opioid antagonists |
| 12/31/2013 | CA2636960C Pharmaceutical composition comprising a specific inhibitor of hedgehog/smoothened signaling and a corticosteroid |
| 12/31/2013 | CA2622579C Use of a dpp-iv inhibitor to reduce hypoglycemic events |
| 12/31/2013 | CA2569468C Ophthalmic formulations including selective alpha 1 antagonists |
| 12/31/2013 | CA2566617C Method and composition for reducing e.coli disease and enhancing performance using bacillus |
| 12/31/2013 | CA2548454C Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 12/31/2013 | CA2527145C Use of iron for treating attention deficit hyperactivity disorder in children |
| 12/31/2013 | CA2523868C Combinations comprising a protein tyrosine kinase receptor antagonist and a chemotherapeutic or naturally occurring, semi-synthetic of synthetic therapeutic agent for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 12/31/2013 | CA2485847C Glucan-based vaccines |
| 12/31/2013 | CA2467908C Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages |
| 12/31/2013 | CA2426030C Methods of treating disorders related to apoe |
| 12/27/2013 | WO2013192274A2 Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy |
| 12/27/2013 | WO2013192240A2 Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of various diseases and disorders |
| 12/27/2013 | WO2013192238A2 Compositions and methods for treatment of diabetes |
| 12/27/2013 | WO2013191225A1 Mucosal immunity-stimulating agent, and oral pharmaceutical composition for treating hpv infection |
| 12/27/2013 | WO2013191168A1 Method for changing eyelid state by administration of freund's complete adjuvant |
| 12/27/2013 | WO2013191167A1 Method for changing eyelid state of hairless animals |
| 12/27/2013 | WO2013189771A1 Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof |
| 12/27/2013 | CA2875619A1 Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof |
| 12/27/2013 | CA2875567A1 Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of various diseases and disorders |
| 12/26/2013 | US20130345409 Growth factor |
| 12/26/2013 | US20130345321 Genipin cross-linked fibrin gels |
| 12/26/2013 | US20130345314 Compositions and methods for treating a damaged cardiovascular element |
| 12/26/2013 | US20130345281 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| 12/26/2013 | US20130345278 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 12/26/2013 | US20130345277 Modulators of GTPase and Use In Relevant Treatment |
| 12/26/2013 | US20130345275 1,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylase |
| 12/26/2013 | US20130345272 Cycloalkyl Ether Compounds and Their Use as Bace Inhibitors |
| 12/26/2013 | US20130345265 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient |
| 12/26/2013 | US20130345248 Cyclohexane-1,2'-Naphthalene-1',2"-Imidazol Compounds and Their Use as Bace |
| 12/26/2013 | US20130345247 Cyclohexane-1,2'-Indene-1',2"-Imidazol Compounds and Their Use as Bace Inhibitors |
| 12/26/2013 | US20130345246 2H-Imidazol-4-Amine Compounds and Their Use as Bace Inhibitors |
| 12/26/2013 | US20130345245 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors |
| 12/26/2013 | US20130345239 Novel crystalline form |
| 12/26/2013 | US20130345232 Methods and compositions for treating a subject for a lymphatic malformation |
| 12/26/2013 | US20130345231 Anticancer therapeutic agents |
| 12/26/2013 | US20130345230 Methods and compositions for modulating calcium channels |
| 12/26/2013 | US20130345227 Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses |
| 12/26/2013 | US20130345220 Compounds and compositions as lxr modulators |
| 12/26/2013 | US20130345216 Certain chemical entities, compositions and methods |
| 12/26/2013 | US20130345214 Lipoxygenase Inhibitors |
| 12/26/2013 | US20130345209 Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof |
| 12/26/2013 | US20130345202 Flumazenil Complexes, Compositions Comprising Same And Uses Thereof |
| 12/26/2013 | US20130345197 Azaindoles useful as inhibitors of jak and other protein kinases |
| 12/26/2013 | US20130345194 Substituted cyclopentyl-azines as casr-active compounds |
| 12/26/2013 | US20130345180 2,4- diaminopyrimidine derivatives |
| 12/26/2013 | US20130345176 NOVEL ESTERS OF 4, 9-DIHYDROXY-NAPHTHO [2, 3-b] FURANS FOR DISEASE THERAPIES |
| 12/26/2013 | US20130345172 Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| 12/26/2013 | US20130345171 Treatment and prevention of cardiovascular disease and thrombosis |
| 12/26/2013 | US20130345135 Inhibition of mypb-c binding to myosin as a treatment for heart failure |
| 12/26/2013 | US20130345128 Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
| 12/26/2013 | US20130345127 Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
| 12/26/2013 | US20130345126 Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| 12/26/2013 | US20130345125 Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| 12/26/2013 | US20130345123 Substituted adipic acid amides and uses thereof |
| 12/26/2013 | US20130345115 Nuclear penetrating h4 tail peptides for the treatment of diseases mediated by impaired or loss of p53 function |
| 12/26/2013 | US20130345114 Agent for Treating Allergic or Hypersensitivity Condition |
| 12/26/2013 | US20130344184 Materials and methods for treatment and diagnosis of disorders associated with oxidative stress |
| 12/26/2013 | US20130344138 Methods of treatment for solid tumors |
| 12/26/2013 | US20130344134 Inhibitors of cyclic amp phosphodiesterases |
| 12/26/2013 | US20130344102 Formulation |
| 12/26/2013 | US20130344091 Compositions and methods for increasing muscle growth |
| 12/26/2013 | US20130344079 Compositions and methods for diagnosing and treating phenylketonuria (pku) |
| 12/26/2013 | US20130344077 Monoclonal antibodies |
| 12/26/2013 | US20130344073 Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders |
| 12/26/2013 | US20130344067 Alk1 receptor and ligand antagonists and uses thereof |
| 12/26/2013 | US20130344065 Combination Treatment with VEGF-C Antagonists |
| 12/26/2013 | US20130344064 Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof |
| 12/26/2013 | US20130344061 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors |
| 12/26/2013 | US20130344060 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 12/26/2013 | US20130344059 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 12/26/2013 | US20130344047 Methods And Composition For Treating Heart Failure And Ischemia |
| 12/26/2013 | US20130344046 Methods For The Dietary Management Of Irritable Bowel Syndrome And Carbohydrate Malabsorption |
| 12/26/2013 | US20130344031 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 12/26/2013 | US20130344030 Macrocyclic inhibitors of flaviviridae viruses |
| 12/26/2013 | US20130344029 Macrocyclic inhibitors of flaviviridae viruses |
| 12/26/2013 | US20130343991 Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer |